MedPath
TGA Approval

HEXAXIM DTPa-hepB-IPV-Hib Suspension for injection in pre-filled syringe (215536)

215536

HEXAXIM DTPa-hepB-IPV-Hib Suspension for injection in pre-filled syringe

Sanofi-Aventis Australia Pty Ltd

September 11, 2014

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/8b592adf4835621bff21ad961c25e80f.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/467d210daa16942c64da2730c5bcf6c3.pdf

Active Ingredients

Diphtheria toxoid

hepatitis B surface antigen

Haemophilus type B polysaccharide

Pertussis filamentous haemagglutinin

Pertussis toxoid

Tetanus toxoid

Tetanus protein

Poliovirus

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

HEXAXIM DTPa-hepB-IPV-Hib Suspension for injection in pre-filled syringe (215536) - TGA 批准文号 | MedPath